載入...
Metastatic renal cell carcinoma patients of T4 stage who are in status of N1 stage or older than 76 years cannot benefit from cytoreductive nephrectomy
BACKGROUND: We aimed to identify which part of the patients with metastatic renal cell carcinoma (mRCC) is not suitable for cytoreductive nephrectomy (CN). METHODS: The data of mRCC patients was acquired from the Surveillance, Epidemiology, and End Results (SEER) database. Multivariate cox regressio...
Na minha lista:
| 發表在: | BMC Cancer |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7470438/ https://ncbi.nlm.nih.gov/pubmed/32883242 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-07351-w |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|